APA (7th ed.) Citation

Fallani, E., Cevenini, F., Lazzerini, P. E., Verdini, A., & Saponara, S. (2022). Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance. Journal of clinical pharmacology, 62(5), 646. https://doi.org/10.1002/jcph.2006

Chicago Style (17th ed.) Citation

Fallani, Elettra, Fabio Cevenini, Pietro Enea Lazzerini, Annalisa Verdini, and Simona Saponara. "Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance." Journal of Clinical Pharmacology 62, no. 5 (2022): 646. https://doi.org/10.1002/jcph.2006.

MLA (9th ed.) Citation

Fallani, Elettra, et al. "Off-Label Use of Hydroxychloroquine in COVID-19: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance." Journal of Clinical Pharmacology, vol. 62, no. 5, 2022, p. 646, https://doi.org/10.1002/jcph.2006.